CY1114885T1 - Βελτιωμενη σταθεροτητα διαλυτοποιησης για δισκια ανθρακικου ασβεστιου - Google Patents

Βελτιωμενη σταθεροτητα διαλυτοποιησης για δισκια ανθρακικου ασβεστιου

Info

Publication number
CY1114885T1
CY1114885T1 CY20131101107T CY131101107T CY1114885T1 CY 1114885 T1 CY1114885 T1 CY 1114885T1 CY 20131101107 T CY20131101107 T CY 20131101107T CY 131101107 T CY131101107 T CY 131101107T CY 1114885 T1 CY1114885 T1 CY 1114885T1
Authority
CY
Cyprus
Prior art keywords
composition
mannitol
solution stability
improved solution
stearate
Prior art date
Application number
CY20131101107T
Other languages
Greek (el)
English (en)
Inventor
Peder Mohr Olsen
Poul Egon Bertelsen
Thomas Thisted
Henrik Ravn Aage
Original Assignee
Takeda Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Nycomed As filed Critical Takeda Nycomed As
Publication of CY1114885T1 publication Critical patent/CY1114885T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CY20131101107T 2008-11-17 2013-12-09 Βελτιωμενη σταθεροτητα διαλυτοποιησης για δισκια ανθρακικου ασβεστιου CY1114885T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08169264 2008-11-17
EP09763835.7A EP2358374B1 (en) 2008-11-17 2009-11-17 Improved dissolution stability of calcium carbonate tablets

Publications (1)

Publication Number Publication Date
CY1114885T1 true CY1114885T1 (el) 2016-12-14

Family

ID=40456895

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131101107T CY1114885T1 (el) 2008-11-17 2013-12-09 Βελτιωμενη σταθεροτητα διαλυτοποιησης για δισκια ανθρακικου ασβεστιου

Country Status (22)

Country Link
US (2) US9101565B2 (https=)
EP (1) EP2358374B1 (https=)
JP (1) JP5523467B2 (https=)
KR (1) KR101807318B1 (https=)
CN (1) CN102215847B (https=)
AU (1) AU2009315917B2 (https=)
BR (1) BRPI0921599B8 (https=)
CA (1) CA2742449C (https=)
CY (1) CY1114885T1 (https=)
DK (1) DK2358374T3 (https=)
EA (1) EA021707B1 (https=)
ES (1) ES2437851T3 (https=)
HR (1) HRP20131084T1 (https=)
IL (1) IL212442A (https=)
MX (1) MX2011004744A (https=)
NZ (1) NZ592528A (https=)
PL (1) PL2358374T3 (https=)
PT (1) PT2358374E (https=)
SI (1) SI2358374T1 (https=)
SM (1) SMT201400014B (https=)
WO (1) WO2010054845A1 (https=)
ZA (1) ZA201103421B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ592528A (en) 2008-11-17 2013-05-31 Nycomed Pharma As Improved dissolution stability of calcium carbonate tablets
WO2011151018A2 (en) 2010-06-01 2011-12-08 Cargill, Incorporated Orodispersible tablets of erythritol and isomalt
EP3260114A1 (en) 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
CN107281216B (zh) * 2017-06-16 2020-05-05 北京济美堂医药研究有限公司 含钙化合物的药物制剂
CN110575440A (zh) * 2018-06-08 2019-12-17 北京新领先医药科技发展有限公司 一种碳酸钙药物组合物的制备方法
MX2022000267A (es) 2019-07-05 2022-02-03 Tecnimede Sociedade Tecnico Medicinal Sa Composiciones comprimidas de macitentan, metodos y usos de las mismas.
JP7774867B2 (ja) * 2021-10-04 2025-11-25 備前化成株式会社 食品錠剤の製造方法
US20260042979A1 (en) * 2022-08-04 2026-02-12 Symrise Ag Process for the Preparation of a Powder or of a Pastille
KR102675165B1 (ko) * 2023-02-20 2024-06-13 동아제약 주식회사 필름 코팅용 조성물 및 이를 포함하는 필름 코팅액

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115553A (en) * 1973-12-10 1978-09-19 Armour Pharmaceutical Company Antacid tablets
US5204115A (en) 1990-12-12 1993-04-20 Suomen Xyrofin Oy Directly compressible xylitol and method
JP2995226B2 (ja) 1992-03-03 1999-12-27 日本ワイスレダリー株式会社 カルシウム含有チユアブル錠
US5405623A (en) 1993-09-22 1995-04-11 Wm. Wrigley Jr. Company Chewing gum compositions and methods for manufacturing same
DE4427137B4 (de) 1993-10-07 2007-08-23 Degussa Gmbh Fällungskieselsäure
US6716454B2 (en) * 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
FR2724844B1 (fr) 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
US5846506A (en) 1994-10-07 1998-12-08 Degussa Aktiengesellschaft Precipitated silicas
DE19617487A1 (de) 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
DK0914818T3 (da) 1996-06-14 2005-07-04 Kyowa Hakko Kogyo Kk Intraoralt hurtigt desintegrerbar tablet
FR2762217B1 (fr) 1997-04-16 2000-09-29 Besins Iscovesco Lab Preparation solide vitamino-calcique, son procede d'obtention et son utilisation
ITFI970184A1 (it) 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
GB9825033D0 (en) 1998-11-13 1999-01-13 Nycomed Pharma As Process
JP2001316249A (ja) 2000-05-11 2001-11-13 Lion Corp 錠剤型医薬組成物
WO2002070013A1 (en) 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co., Ltd. Utilization of spray-dried powder containing sugar alcohol
JPWO2002069934A1 (ja) 2001-03-06 2004-07-02 協和醗酵工業株式会社 口腔内速崩壊性製剤
BR0211117A (pt) * 2001-07-16 2004-06-22 Astrazeneca Ab Tablete multiparticulado, processo para a manufatura e uso do mesmo, e, método e tratamento de distúrbios gastrointestinais
ES2192136B1 (es) 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
DE20216314U1 (de) 2002-10-22 2003-12-04 Dhw Deutsche Hydrierwerke Gmbh Rodleben Sprühgetrockneter Xylitol und aus diesem hergestellte Komprimate
MXPA06013608A (es) * 2004-05-24 2007-04-26 Nycomed Pharma As Particulado que comprende un compuesto que contiene calcio y un alcohol de azucar.
JP4996458B2 (ja) * 2004-06-01 2012-08-08 ニコメド ファーマ エイエス 活性物質としてカルシウム含有化合物を含み、咀嚼し、舐め、飲み込むことのできる錠剤
DE602006001295D1 (de) * 2005-02-03 2008-07-03 Nycomed Pharma As Schmelzgranulation einer zusammensetzung mit einer calziumhaltigen verbindung
DE602006016641D1 (de) 2005-12-07 2010-10-14 Nycomed Danmark Aps Vorkompaktierte calciumhaltige zusammensetzungen
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
CN101584153B (zh) 2007-01-16 2012-10-10 皇家飞利浦电子股份有限公司 混合型定向终端的设备发现
NZ592528A (en) 2008-11-17 2013-05-31 Nycomed Pharma As Improved dissolution stability of calcium carbonate tablets

Also Published As

Publication number Publication date
CA2742449C (en) 2018-04-24
WO2010054845A1 (en) 2010-05-20
SMT201400014B (it) 2014-03-07
HK1162354A1 (en) 2012-08-31
AU2009315917B2 (en) 2014-11-20
AU2009315917A1 (en) 2010-05-20
DK2358374T3 (da) 2013-11-11
US9999634B2 (en) 2018-06-19
US9101565B2 (en) 2015-08-11
NZ592528A (en) 2013-05-31
JP5523467B2 (ja) 2014-06-18
EP2358374A1 (en) 2011-08-24
KR101807318B1 (ko) 2018-01-10
US20160022732A1 (en) 2016-01-28
CA2742449A1 (en) 2010-05-20
JP2012508706A (ja) 2012-04-12
IL212442A (en) 2015-10-29
KR20110086592A (ko) 2011-07-28
EA201170695A1 (ru) 2011-12-30
BRPI0921599B1 (pt) 2020-08-18
BRPI0921599B8 (pt) 2021-05-25
PT2358374E (pt) 2013-12-09
CN102215847B (zh) 2014-07-16
ES2437851T3 (es) 2014-01-14
ZA201103421B (en) 2012-10-31
MX2011004744A (es) 2011-05-30
EA021707B1 (ru) 2015-08-31
HRP20131084T1 (hr) 2013-12-20
CN102215847A (zh) 2011-10-12
US20110287098A1 (en) 2011-11-24
BRPI0921599A2 (pt) 2016-02-10
IL212442A0 (en) 2011-06-30
SI2358374T1 (sl) 2014-01-31
EP2358374B1 (en) 2013-09-18
PL2358374T3 (pl) 2014-03-31

Similar Documents

Publication Publication Date Title
CY1114885T1 (el) Βελτιωμενη σταθεροτητα διαλυτοποιησης για δισκια ανθρακικου ασβεστιου
CY1126116T1 (el) Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη
AR054114A1 (es) Composiciones farmaceuticas que comprenden imatinib y un retardador de la liberacion
ES2535839T3 (es) Composición de un gel que comprende pectina ligeramente metoxilada
UA106878C2 (uk) Фармацевтична композиція, що містить 4-[3-(4-циклопропанкарбонілпіперазин-1-карбоніл)-4-фторбензил]-2н-фталазин-1-он або його сіль, або сольват, у твердій дисперсії з матричним полімером коповідоном
NZ604055A (en) Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate
PE20120028A1 (es) Nueva composicion a base de acido gamma-hidroxibutirico
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
UY31867A (es) Nuevas formulaciones farmacéuticas sólidas que comprenden bibw 2992
CY1108521T1 (el) Παρασκευη αλδεσλευκινης για φαρμακευτικη χρηση
EA201190319A1 (ru) Твердая фармацевтическая композиция, содержащая ривароксабан
TW200621313A (en) Pharmaceutical compositions
ECSP088980A (es) Composicion farmacéutica que comprende amlodipina y losartán
PE20070698A1 (es) Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
AR061093A1 (es) Composiciones de calcio
AR051048A1 (es) Sustituto del azucar bajo en calorias o sin calorias, no higroscopico
AR099385A1 (es) Formulaciones de 3-(5-amino-2-metil-4-oxo-4h-quinazolin-3-il)-piperidina-2,6-diona
MX2010009147A (es) Derivados de pirrolidinilo y usos de los mismos.
GT200600144AA (es) 1h-quinazolin-2,4-dionas (solicitud fraccionaria, derivada de la solicitud de patente de invencion pi-2006-00144)
HRP20110459T1 (hr) Upotreba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju ozljeda kralježnične moždine
WO2006128847A3 (en) Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
ATE474558T1 (de) Pharmazeutische formulierungen mit irbesartan
EA201892632A1 (ru) Фармацевтическая композиция, содержащая комбинацию мемантина и мелатонина
DK1815850T3 (da) Controlled release formular af valproinsyreforbindelse og dets derivater
BR112014019155A8 (pt) Comprimido antiácido